Clinical Trial Update: CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer [NA]

View source ↗

Summary

This clinical trial update discusses the use of CyberKnife stereotactic radiosurgery for patients with low- and intermediate-risk prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Riverside Community Hospital, California | Conditions: Prostate Cancer | NA | Status: UNKNOWN